Home/Filings/4/0001144204-14-005261
4//SEC Filing

PHARMATHENE, INC 4

Accession 0001144204-14-005261

$ALTCIK 0001326190operating

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:02 PM ET

Size

5.5 KB

Accession

0001144204-14-005261

Insider Transaction Report

Form 4
Period: 2014-01-29
CHANG LINDA L
SVP & CFO
Transactions
  • Award

    Stock Options (right to buy)

    2014-01-29+210,000210,000 total
    Exercise: $1.94Exp: 2024-01-29Common Stock (210,000 underlying)
Footnotes (2)
  • [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
  • [F2]On January 29, 2014, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.94 per share.

Issuer

PHARMATHENE, INC

CIK 0001326190

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001326190

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:02 PM ET
Size
5.5 KB